Delivery Order SPM20005D0905-F354
Award Date 9/15/13
Potential Completion Date 9/15/13
Potential Value $3.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 16, 2026, for VABYSMO 6 mg/0.05 ml vials with a ceiling value of $7,187.10 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. DMS...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 23, 2026, with a ceiling value of $22,054.20 for supply of VABYSMO 6 MG/0.05 ML syringes under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations worldwide. Place of performance is Park Ridge,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 9, 2026, for Perjeta 420 mg/14 mL vials, with a ceiling value of $49,058.10 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 22, 2026, for diazepam 5 mg/ml (10 2-ml vials) with a ceiling value of $4,822.48 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. The underlying IDC,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for Perjeta 420 mg/14 ml vials with a ceiling value of $49,058.10 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract vehicle for pharmaceutical supply to Department of Defense healthcare facilities worldwide. The parent contract, awarded to DMS Pharmaceutical Group on November 13, 2025,...
- The Defense Logistics Agency issued a $5,881.12 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 11, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for VABYSMO 6 MG/0.05 ML syringes. PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract authorizing firm fixed-price orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a $3,795 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on March 25, 2026, for diazepam injection under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable supply to Department of Defense healthcare facilities worldwide. Place of performance is Park Ridge, IL. The order carries a firm...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 6, 2026, for procainamide 1 gram/10 ml vial with a ceiling value of $6,123.08, issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical...
- The Defense Logistics Agency issued a $1,593.02 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on March 9, 2026, for diazepam injection under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a DLA-managed indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic pharmaceuticals, biologics, and medical consumables to support Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a $3,492.12 delivery order to DMS Pharmaceutical Group Inc. on April 2, 2026, for Avastin 100 mg/4 mL vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group Inc. is a...